Expression of both ROPN1B and NY-ESO-1 was seen in 9 cases (n = 9/61, 14.8%), where tumour cells within cores showed instances of co-expression or exclusive expression of ROPN1B and/or NY-ESO-1 (Figure 2 and Figure 3). Here, CTAG1B is linked to neoplasm.